The preclinical toxicology of salmeterol hydroxynaphthoate.
about
Regulatory toxicology considerations for the development of inhaled pharmaceuticals.Foamy macrophage responses in the rat lung following exposure to inhaled pharmaceuticals: a simple, pragmatic approach for inhaled drug development.A 3D human airway model enables prediction of respiratory toxicity of inhaled drugs in vitro.
P2860
The preclinical toxicology of salmeterol hydroxynaphthoate.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The preclinical toxicology of salmeterol hydroxynaphthoate.
@en
The preclinical toxicology of salmeterol hydroxynaphthoate.
@nl
type
label
The preclinical toxicology of salmeterol hydroxynaphthoate.
@en
The preclinical toxicology of salmeterol hydroxynaphthoate.
@nl
prefLabel
The preclinical toxicology of salmeterol hydroxynaphthoate.
@en
The preclinical toxicology of salmeterol hydroxynaphthoate.
@nl
P2093
P2860
P356
P1476
The preclinical toxicology of salmeterol hydroxynaphthoate.
@en
P2093
P2860
P304
P356
10.1177/0960327110363335
P577
2010-03-10T00:00:00Z